Metrion Biosciences Ltd., a specialist ion channel CRO and drug discovery company, and LifeArc, a UK medical research charity, have extended their neuroscience drug discovery collaboration for 12 months, as a result of the continued success under the agreement.   The collaboration, initially signed in January 2019, is focused on the discovery of novel selective small molecular modulators of a specific two-pore domain potassium ion channel target, identified as likely to be involved in neurolog...